<DOC>
	<DOC>NCT01578837</DOC>
	<brief_summary>The study is a combined Phase-I like (safety) and Phase-II like (efficacy) double blind randomized placebo controlled trial. The objective is to investigate whether the combination of AG and Rg3-enriched Korean Red ginseng added to conventional medical treatment are effective and safe in the long-term management of high blood pressure while managing type 2 diabetes. Eighty-five subjects with type 2 diabetes and concomitant high blood pressure (key inclusion criteria: HbA1c ≥ 6.5%- ≤ 8.0%) will be recruited for the study.</brief_summary>
	<brief_title>Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>between the age of 40 and 75 years type 2 diabetes (at least 1 year duration, HbA1c ≥ 6.5% ≤ 8.0%, treated with diet and/or oral hypoglycemic medications) clinically diagnosed and treated hypertension according to Canadian Diabetes Association Clinical Practice Guidelines normal thyroid, kidney and liver functions female subjects recruited for the study must be postmenopausal or had absence of menstruation for ≥ 1 year or is taking contraceptive precautions insulin therapy history of angina, myocardial infarction or stroke systolic blood pressure &gt;160 mmHg and/or diastolic blood pressure &gt;100 mmHg use of ginseng within 1 month start of study BMI &gt;35 kg/m2 smoking cigarettes alcohol intake of &gt; 2 drinks/day recently given blood have an upcoming planned surgery GFR &lt;60 mL/min/1.73m2 prolonged QT (&gt;20 ms) interval as assessed by ECG changes to use of natural health products that may effect blood pressure and/or diabetes weight change more than +/ 3 kg/month HIV infection, inflammatory bowel disease, celiac disease, heart disease, bleeding disorder, sleep disorder, arrhythmia pregnant or breastfeeding use of anticoagulant (excluding aspirin), antiplatelet, sedative, sympathomimetic, photosensitizing or antidepressant drugs hormone replacement therapy, furosemide, morphine, glucocorticoids presence of any conditions which, in the opinion of the Qualified Investigator, might jeopardize the health and safety of the subject or study personnel, or adversely affect the study results known sensitivity or allergy to any test product or placebo ingredients</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>